Pacer Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
Other funds holding MIRM
FLSM
JT
Pacer Advisors's MIRM Position: Q2 2026 in Review
Pacer Advisors opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 490 shares worth $57K. The stake represents ﹤0.01% of the portfolio and ranks #2006 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in MIRM as recently as Q2 2024.
Pacer Advisors first reported a position in MIRM in Q1 2024 and has held it in 3 quarters since. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.
- Pacer Advisors held 490 shares of Mirum Pharmaceuticals worth $57K as of Q2 2026.
- Mirum Pharmaceuticals was a new Pacer Advisors position in Q2 2026.
- Mirum Pharmaceuticals made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2006 holding.
- Pacer Advisors first reported a position in Mirum Pharmaceuticals in Q1 2024 and has held it in 3 quarters since.
- 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.
Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.